Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
195
-
Total 13F shares, excl. options
-
137M
-
Shares change
-
+3.27M
-
Total reported value, excl. options
-
$1.01B
-
Value change
-
+$22.1M
-
Put/Call ratio
-
0.39
-
Number of buys
-
91
-
Number of sells
-
-72
-
Price
-
$7.33
Significant Holders of OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) as of Q1 2025
217 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - COMMON STOCK as of Q1 2025.
OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) has 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 137M shares
of 159M outstanding shares and own 86.17% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (14.3M shares), Summer Road LLC (13.9M shares), VR ADVISER, LLC (12.8M shares), BlackRock, Inc. (12M shares), VANGUARD GROUP INC (8.36M shares), Avoro Capital Advisors LLC (8.06M shares), TCG Crossover Management, LLC (5.32M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (5.2M shares), CITADEL ADVISORS LLC (4.81M shares), and GEODE CAPITAL MANAGEMENT, LLC (3.42M shares).
This table shows the top 195 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.